0001593968-22-000421.txt : 20220208 0001593968-22-000421.hdr.sgml : 20220208 20220208170144 ACCESSION NUMBER: 0001593968-22-000421 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220206 FILED AS OF DATE: 20220208 DATE AS OF CHANGE: 20220208 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Colangelo Dominick CENTRAL INDEX KEY: 0001313403 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35280 FILM NUMBER: 22602436 MAIL ADDRESS: STREET 1: 1000 WINTER ST. STREET 2: SUITE 2200 CITY: WALTHAM STATE: MA ZIP: 02451 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Vericel Corp CENTRAL INDEX KEY: 0000887359 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 943096597 STATE OF INCORPORATION: MI FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 64 SIDNEY ST. CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 7349305555 MAIL ADDRESS: STREET 1: 64 SIDNEY ST. CITY: CAMBRIDGE STATE: MA ZIP: 02139 FORMER COMPANY: FORMER CONFORMED NAME: AASTROM BIOSCIENCES INC DATE OF NAME CHANGE: 19960428 4 1 primary_01.xml PRIMARY DOCUMENT X0306 4 2022-02-06 0000887359 Vericel Corp VCEL 0001313403 Colangelo Dominick C/O VERICEL CORPORATION 64 SIDNEY STREET CAMBRIDGE MA 02139 true true false false President and CEO Common Stock 2022-02-06 4 M false 6937 0 A 150170 D Common Stock 2022-02-06 4 F false 3049 33.91 D 147121 D Restricted Stock Unit 2022-02-06 4 M false 6937 33.91 D Common Stock 6937 6938 D The shares of common stock were acquired by the Reporting person as a result of the vesting of RSUs granted to the Reporting Person on February 6, 2019. The remaining RSUs will vest on February 6, 2023. These shares were withheld by the Issuer to satisfy the tax withholding requirements in connection with the vesting of Restricted Stock Units. Each Restricted Stock Unit (RSU) represents a contingent right to receive one share of common stock of Vericel Corporation. No expiration date for this type of award. /s/ Sean Flynn, as Attorney-in-Fact for Dominick C. Colangelo 2022-02-08